Proto Labs (NYSE:PRLB - Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, November 1st. Analysts expect the company to announce earnings of $0.33 per share for the quarter. Proto Labs has set its Q3 guidance at $0.29-0.37 EPS and its Q3 2024 guidance at 0.290-0.370 EPS.Investors that are interested in participating in the company's conference call can do so using this link.
Proto Labs (NYSE:PRLB - Get Free Report) last released its quarterly earnings results on Friday, August 2nd. The industrial products company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. Proto Labs had a return on equity of 3.60% and a net margin of 4.86%. The business had revenue of $125.60 million during the quarter, compared to the consensus estimate of $126.25 million. During the same quarter in the previous year, the company posted ($0.01) EPS. The business's revenue was up 2.7% on a year-over-year basis. On average, analysts expect Proto Labs to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Proto Labs Trading Down 0.4 %
Shares of NYSE PRLB traded down $0.12 during trading on Friday, reaching $26.71. The company had a trading volume of 133,670 shares, compared to its average volume of 184,267. The stock has a market capitalization of $671.76 million, a PE ratio of 27.82 and a beta of 1.31. The stock has a 50-day moving average price of $29.04 and a two-hundred day moving average price of $30.56. Proto Labs has a twelve month low of $23.01 and a twelve month high of $41.87.
Analyst Ratings Changes
Several brokerages have commented on PRLB. Cantor Fitzgerald restated an "overweight" rating and set a $44.00 price target on shares of Proto Labs in a research note on Tuesday, July 30th. StockNews.com downgraded Proto Labs from a "strong-buy" rating to a "buy" rating in a report on Monday, August 5th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Proto Labs in a research report on Monday, August 5th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $41.00.
Get Our Latest Report on PRLB
Insider Activity
In other news, CEO Robert Bodor acquired 3,480 shares of the business's stock in a transaction on Friday, September 6th. The shares were purchased at an average price of $28.68 per share, for a total transaction of $99,806.40. Following the acquisition, the chief executive officer now directly owns 80,878 shares of the company's stock, valued at $2,319,581.04. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.20% of the company's stock.
About Proto Labs
(
Get Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
See Also
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.